Misframed ubiquitin and impaired protein quality control; an early event in Alzheimer’s disease
Aβ plaque formation is a prominent cellular hallmark of Alzheimer’s disease (AD). To date, immunization trials in AD patients have not been effective in terms of curing or ameliorating dementia. In addition, γ-secretase inhibitor strategies await clinical improvements in AD. These approaches were ba...
Main Authors: | Romina Jozefa Gentier, Fred W. Van eLeeuwen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-09-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2015.00047/full |
Similar Items
-
Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation
by: Hiroyuki Shimada, et al.
Published: (2020-06-01) -
Biomarkers in the diagnosis of neurodegenerative diseases
by: Syed S. Haque
Published: (2022-12-01) -
Modeling Alzheimer’s Disease in <i>Caenorhabditis elegans</i>
by: Javier Alvarez, et al.
Published: (2022-01-01) -
Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
by: Florence Haut, et al.
Published: (2023-12-01) -
Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
by: Long Wang, et al.
Published: (2023-11-01)